Cardinal profit up on generic drugs, medical products
Feb 5 (Reuters) - Drug wholesaler Cardinal Health Inc said on Tuesday that quarterly earnings had risen 16 percent, driven by increased sales of generic medicines and medical products such as surgical gowns and instruments.
Net earnings in the second quarter ended Dec. 31 rose to $303 million, or 88 cents a share, from $262 million, or 75 cents a share, a year earlier.
Earnings from continuing operations excluding one-time items rose to 93 cents a share from 81 cents.
- Alabama man gets $1,000 in police settlement, his lawyers get $459,000
- Canada PM vows crackdown after capital shocked by fatal attacks |
- Man arrested after jumping White House fence, causing lockdown
- Probe: Athletes took fake classes at University of North Carolina
- U.S.-led air strikes killed 521 fighters, 32 civilians in Syria: monitor